ID   MOC23
AC   CVCL_ZD37
SY   Mouse Oral Cancer 23
DR   GEO; GSM1213092
DR   GEO; GSM1213093
DR   GEO; GSM1213094
DR   Wikidata; Q98127276
RX   PubMed=22086849;
RX   PubMed=24668645;
RX   PubMed=25729643;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 5
//
RX   PubMed=22086849; DOI=10.1158/0008-5472.CAN-11-1831; PMCID=PMC3286642;
RA   Judd N.P., Winkler A.E., Murillo-Sauca O., Brotman J.J., Law J.H.,
RA   Lewis J.S. Jr., Dunn G.P., Bui J.D., Sunwoo J.B., Uppaluri R.;
RT   "ERK1/2 regulation of CD44 modulates oral cancer aggressiveness.";
RL   Cancer Res. 72:365-374(2012).
//
RX   PubMed=24668645; DOI=10.1158/1078-0432.CCR-14-0205; PMCID=PMC4096804;
RA   Onken M.D., Winkler A.E., Kanchi K.-L., Chalivendra V., Law J.H.,
RA   Rickert C.G., Kallogjeri D., Judd N.P., Dunn G.P., Piccirillo J.F.,
RA   Lewis J.S. Jr., Mardis E.R., Uppaluri R.;
RT   "A surprising cross-species conservation in the genomic landscape of
RT   mouse and human oral cancer identifies a transcriptional signature
RT   predicting metastatic disease.";
RL   Clin. Cancer Res. 20:2873-2884(2014).
//
RX   PubMed=25729643; DOI=10.1016/j.gdata.2014.11.006; PMCID=PMC4340082;
RA   Chalivendra V., Kanchi K.-L., Onken M.D., Winkler A.E., Mardis E.R.,
RA   Uppaluri R.;
RT   "Genomic analysis to define molecular basis of aggressiveness in a
RT   mouse model of oral cancer.";
RL   Genom. Data 3:61-62(2015).
//